152 related articles for article (PubMed ID: 12840031)
1. Stereoselective interactions of peptide inhibitors with the beta-amyloid peptide.
Chalifour RJ; McLaughlin RW; Lavoie L; Morissette C; Tremblay N; Boulé M; Sarazin P; Stéa D; Lacombe D; Tremblay P; Gervais F
J Biol Chem; 2003 Sep; 278(37):34874-81. PubMed ID: 12840031
[TBL] [Abstract][Full Text] [Related]
2. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.
Gordon DJ; Sciarretta KL; Meredith SC
Biochemistry; 2001 Jul; 40(28):8237-45. PubMed ID: 11444969
[TBL] [Abstract][Full Text] [Related]
4. d-Enantiomeric RTHLVFFARK-NH
Liu W; Dong X; Sun Y
ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
[TBL] [Abstract][Full Text] [Related]
5. The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology.
Seilheimer B; Bohrmann B; Bondolfi L; Müller F; Stüber D; Döbeli H
J Struct Biol; 1997 Jun; 119(1):59-71. PubMed ID: 9216088
[TBL] [Abstract][Full Text] [Related]
6. A beta-amino acid modified heptapeptide containing a designed recognition element disrupts fibrillization of the amyloid beta-peptide.
Castelletto V; Hamley IW; Lim T; De Tullio MB; Castaño EM
J Pept Sci; 2010 Sep; 16(9):443-50. PubMed ID: 20648477
[TBL] [Abstract][Full Text] [Related]
7. TANGO-Inspired Design of Anti-Amyloid Cyclic Peptides.
Lu X; Brickson CR; Murphy RM
ACS Chem Neurosci; 2016 Sep; 7(9):1264-74. PubMed ID: 27347598
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
Kirkitadze MD; Condron MM; Teplow DB
J Mol Biol; 2001 Oct; 312(5):1103-19. PubMed ID: 11580253
[TBL] [Abstract][Full Text] [Related]
9. Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid beta(25-35) peptide as analyzed by single alanine substitution.
Sato K; Wakamiya A; Maeda T; Noguchi K; Takashima A; Imahori K
J Biochem; 1995 Dec; 118(6):1108-11. PubMed ID: 8720122
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation.
Soto C; Kindy MS; Baumann M; Frangione B
Biochem Biophys Res Commun; 1996 Sep; 226(3):672-80. PubMed ID: 8831674
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of β-amyloid peptide self-assembly and cytotoxicity by poly(LVFF-co-β-amino ester).
Xie H; Qiao Z; Wang H; Duan H; Yang Y; Wang C
J Pept Sci; 2015 Jul; 21(7):608-14. PubMed ID: 25931322
[TBL] [Abstract][Full Text] [Related]
12. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of clicked curcumin and clicked KLVFFA conjugates as inhibitors of beta-amyloid fibril formation.
Ouberai M; Dumy P; Chierici S; Garcia J
Bioconjug Chem; 2009 Nov; 20(11):2123-32. PubMed ID: 19821579
[TBL] [Abstract][Full Text] [Related]
14. The influence of the carboxyl terminus of the Alzheimer Abeta peptide on its conformation, aggregation, and neurotoxic properties.
Soreghan B; Pike C; Kayed R; Tian W; Milton S; Cotman C; Glabe CG
Neuromolecular Med; 2002; 1(1):81-94. PubMed ID: 12025818
[TBL] [Abstract][Full Text] [Related]
15. Protein L-isoaspartyl O-methyltransferase inhibits amyloid beta fibrillogenesis in vitro.
Jung G; Ryu J; Heo J; Lee SJ; Cho JY; Hong S
Pharmazie; 2011 Jul; 66(7):529-34. PubMed ID: 21812329
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement.
Morimoto A; Irie K; Murakami K; Masuda Y; Ohigashi H; Nagao M; Fukuda H; Shimizu T; Shirasawa T
J Biol Chem; 2004 Dec; 279(50):52781-8. PubMed ID: 15459202
[TBL] [Abstract][Full Text] [Related]
17. In vitro fibrillogenesis of the amyloid beta 1-42 peptide: cholesterol potentiation and aspirin inhibition.
Harris JR
Micron; 2002; 33(7-8):609-26. PubMed ID: 12475558
[TBL] [Abstract][Full Text] [Related]
18. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions.
McLaurin J; Fraser PE
Eur J Biochem; 2000 Nov; 267(21):6353-61. PubMed ID: 11029577
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induced in neuronal cells by C-terminal amyloid beta-fragments is correlated with their aggregation properties in phospholipid membranes.
Demeester N; Baier G; Enzinger C; Goethals M; Vandekerckhove J; Rosseneu M; Labeur C
Mol Membr Biol; 2000; 17(4):219-28. PubMed ID: 11302375
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation.
Hughes E; Burke RM; Doig AJ
J Biol Chem; 2000 Aug; 275(33):25109-15. PubMed ID: 10825171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
